Fig. 1From: Autoantibody signature in hepatocellular carcinoma using seromicsStudy design using seromics. A large cohort of 1253 serum samples, including 611 HCC patients, 249 patients with liver cirrhosis (cirrhotic), and 393 healthy controls (healthy), were enrolled for discovery and evaluation of potential serum AAbs as HCC diagnostic biomarkersBack to article page